Page last updated: 2024-11-13
c.i. 42640
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Acid Violet 6B: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 23691992 |
| MeSH ID | M0048925 |
Synonyms (66)
| Synonym |
|---|
| 550x5x78wk , |
| violet kysela 49 |
| violet potravinarska 2 |
| unii-550x5x78wk |
| benzenemethanaminium, n-(4-((4-(dimethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, inner salt, sodium salt (1:1) |
| fd & c violet no. 1 |
| acid violet 6b |
| acid violet |
| c.i. acid violet 49 (sodium salt) |
| dispersed violet 12197 |
| acid fast violet 5bn |
| ci 42640 |
| cogilor violet 411.12 |
| pergacid violet 2b |
| benzyl violet 3b |
| calcocid violet 4bns |
| c.i. 42640 |
| fd&c violet no. 1 |
| acid violet s |
| c.i. food violet 2 |
| ci acid violet 49, sodium salt |
| intracid violet 4bns |
| eriosin violet 3b |
| violet 5b |
| c.i. acid violet 49 |
| polaxal violet 6b |
| acid violet 4bns |
| ci food violet 2 |
| violet 2 |
| fast acid violet 5bn |
| einecs 216-901-9 |
| food violet 2 |
| aizen acid violet 5bh |
| ci acid violet 49 |
| acilan violet s4bn |
| fd and c violet no. 1 |
| ccris 80 |
| fd and c violet 1 |
| violet potravinarska 2 [czech] |
| pergacid violet 3b |
| kiton violet 4bns |
| ammonium, (4-(p-(dimethylamino)-alpha-(p-(ethyl(m-sulfobenzyl)amino)phenyl)benzylidene)-2,5-cyclohexadien-1-ylidene)ethyl(m-sulfobenzyl)-, hydroxide, inner salt, sodium salt |
| benzenemethanaminium, n-(4-((4-(dimethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt |
| (4-((4-(dimethylamino)phenyl)(4-(ethyl(3-sulphonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)(ethyl)(3-sulphonatobenzyl)ammonium, sodium salt |
| af violet no. 1 |
| coomassie violet |
| formyl violet s4bn |
| a.f. violet no. 1 |
| aizen food violet no. 1 |
| (4-(p-(dimethylamino)-alpha-(p-(ethyl(m-sulfobenzyl)amino)phenyl)benzylidene)-2,5-cyclohexadien-1-ylidene)ethyl(m-sulfobenzyl)ammonium hydroxide inner salt |
| tertracid brilliant violet 6b |
| 11386 violet |
| acid violet 5bn |
| violet no. 1 |
| d and c violet no. 1 |
| violet 6b |
| hsdb 2934 |
| benzenemethanaminium, n-(4-((4-(dimethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, inner salt, sodium salt |
| violet kysela 49 [czech] |
| benzyl violet 4b |
| [4-[bis[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium |
| benzyl violet [ii] |
| acid violet 6b [hsdb] |
| (4-((4-(dimethylamino)phenyl)(4-(ethyl(3-sulphonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien- 1-ylidene)(ethyl)(3-sulphonatobenzyl)ammonium, sodium salt |
| fd&c violet no. 1 (delisted) |
| sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.79
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.79) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||